Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

NCT07477639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis (SPMS)
Multiple Sclerosis
Multiple Sclerosis (MS) Primary Progressive
Multiple Sclerosis (MS) Secondary Progressive

Interventions

BIOLOGICAL: TRX319
DRUG: Bendamustine

Sponsor

Tr1X, Inc.